Breaking News, Financial News

4Q Financial Reports: Lilly ICOS

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lilly ICOS 4Q Revenues: $174.5 million (+39%) 4Q Earnings: $61.4 million (loss of $31.4 million in 4Q2004) FY Revenues: $610.7 million (+36%) FY Earnings: $37.8 million (loss of $262 million in 4Q2004) Comments: The increase in total revenue reflects continued growth of Cialis. Worldwide sales of Cialis for the year totaled $746.6 million, up 35%. The company’s first profitable quarter resulted from an increase of $49 million in total revenue and a reduction of $43.8 m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters